The bone wax market was valued at $53.1 million in 2023, and is projected to reach $73.0 million by 2033, growing at a CAGR of 3.2% from 2024 to 2033.
Bone wax is a mixture of beeswax, paraffin, and isopropyl palmitate, a wax-softening agent, used in surgical procedures to control bleeding from bone surfaces. Its pliable nature allows it to be easily molded and applied directly to the bone, effectively sealing bleeding points by mechanically blocking blood vessels. Bone wax is commonly used in orthopedic, neurosurgical, and cardiothoracic surgeries, particularly when working with the sternum or other bones prone to bleeding.
The growth of the global bone wax market is driven by rise in number of orthopedic, neurosurgical, and cardiovascular surgeries. According to a study published in 2020 by the National Institutes of Health - world's foremost medical research centers - approximately 310 million major surgeries are performed each year; around 40 to 50 million in the U.S. and 20 million in Europe. Furthermore, surge in geriatric population notably contributes toward the market growth. This is attributed to the fact that aged individuals are highly susceptible to conditions such as osteoporosis and other bone-related diseases, as minerals in bones of aged individuals start to leech out, making them brittle, fragile, and easily breakable, thereby necessitating the need for bone wax. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050. Furthermore, a significant trend is the development and adoption of biodegradable bone wax, which significantly boosts the market growth. Traditional bone wax, which is non-resorbable, has been associated with complications like impaired bone healing and infection. In response, manufacturers are introducing bioresorbable options that reduce these risks while still effectively controlling bleeding. However, concerns associated with traditional bone wax hamper the market growth. For instance, traditional bone wax is non-resorbable and can lead to complications such as impaired bone healing, foreign body reactions, and an increased risk of infection. Moreover, availability and preference for alternative hemostatic agents, such as fibrin sealants, gelatin sponges, and oxidized cellulose, which may offer better resorption and fewer complications, are restraining the growth of the bone wax market. On the contrary, innovations in surgical techniques and the development of more efficient and biocompatible bone wax formulations are offering lucrative opportunities for the market growth during the forecast period. Furthermore, with heightened awareness of surgical site infections, there is a growing trend toward bone wax products that incorporate antimicrobial properties. These advanced formulations aim to reduce the risk of post-operative infections, particularly in high-risk surgeries such as those involving the spine or cranium. Such developments are expected to open new avenues for the market growth in the coming years.
The global bone wax market is segmented into product, application, end user, and region. By product, the market is divided into absorbable bone wax and non-absorbable bone wax. On the basis of application, it is classified into orthopedic surgery, thoracic surgery, neurosurgery, and others. Depending on end user, it is categorized into specialty clinics, hospitals, and ambulatory surgery centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
On the basis of application, the orthopedic segment was the major shareholder in 2023.
Depending on end user, hospital emerged as the leading segment in 2023.
Region wise, North America dominated the market share in 2023; however, Asia-Pacific is expected to register the highest CAGR during the forecast period.
Bone wax is a mixture of beeswax, paraffin, and isopropyl palmitate, a wax-softening agent, used in surgical procedures to control bleeding from bone surfaces. Its pliable nature allows it to be easily molded and applied directly to the bone, effectively sealing bleeding points by mechanically blocking blood vessels. Bone wax is commonly used in orthopedic, neurosurgical, and cardiothoracic surgeries, particularly when working with the sternum or other bones prone to bleeding.
The growth of the global bone wax market is driven by rise in number of orthopedic, neurosurgical, and cardiovascular surgeries. According to a study published in 2020 by the National Institutes of Health - world's foremost medical research centers - approximately 310 million major surgeries are performed each year; around 40 to 50 million in the U.S. and 20 million in Europe. Furthermore, surge in geriatric population notably contributes toward the market growth. This is attributed to the fact that aged individuals are highly susceptible to conditions such as osteoporosis and other bone-related diseases, as minerals in bones of aged individuals start to leech out, making them brittle, fragile, and easily breakable, thereby necessitating the need for bone wax. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050. Furthermore, a significant trend is the development and adoption of biodegradable bone wax, which significantly boosts the market growth. Traditional bone wax, which is non-resorbable, has been associated with complications like impaired bone healing and infection. In response, manufacturers are introducing bioresorbable options that reduce these risks while still effectively controlling bleeding. However, concerns associated with traditional bone wax hamper the market growth. For instance, traditional bone wax is non-resorbable and can lead to complications such as impaired bone healing, foreign body reactions, and an increased risk of infection. Moreover, availability and preference for alternative hemostatic agents, such as fibrin sealants, gelatin sponges, and oxidized cellulose, which may offer better resorption and fewer complications, are restraining the growth of the bone wax market. On the contrary, innovations in surgical techniques and the development of more efficient and biocompatible bone wax formulations are offering lucrative opportunities for the market growth during the forecast period. Furthermore, with heightened awareness of surgical site infections, there is a growing trend toward bone wax products that incorporate antimicrobial properties. These advanced formulations aim to reduce the risk of post-operative infections, particularly in high-risk surgeries such as those involving the spine or cranium. Such developments are expected to open new avenues for the market growth in the coming years.
The global bone wax market is segmented into product, application, end user, and region. By product, the market is divided into absorbable bone wax and non-absorbable bone wax. On the basis of application, it is classified into orthopedic surgery, thoracic surgery, neurosurgery, and others. Depending on end user, it is categorized into specialty clinics, hospitals, and ambulatory surgery centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By product, the non-absorbable bone wax segment dominated the market, in terms of share, in 2023.On the basis of application, the orthopedic segment was the major shareholder in 2023.
Depending on end user, hospital emerged as the leading segment in 2023.
Region wise, North America dominated the market share in 2023; however, Asia-Pacific is expected to register the highest CAGR during the forecast period.
Competition Analysis
Competitive analysis and profiles of the major players in the global bone wax market include Zimmer Biomet Holdings, Inc., Medline Industries, Inc., Medtronic Plc, B Braun Melsungen AG, Baxter International, Inc, Johnson & Johnson, Dolphin Sutures, SMI AG, Orion Sutures India Pvt. Ltd., and Universal Suture These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to gain a strong foothold in the global market.Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Product
- Absorbable Bone Wax
- Non-Absorbable Bone Wax
By Application
- Orthopedic Surgery
- Thoracic Surgery
- Neurosurgery
- Others
By End User
- Specialty Clinics
- Hospitals
- Ambulatory Surgery Centers
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Zimmer Biomet Holdings, Inc.
- Medline Industries, Inc.
- Medtronic plc
- B Braun Melsungen AG
- Baxter International, Inc
- Johnson & Johnson
- Dolphin Sutures
- SMI AG
- Orion Sutures India Pvt. Ltd
- Universal Suture
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET LANDSCAPE
CHAPTER 4: BONE WAX MARKET, BY PRODUCT
CHAPTER 5: BONE WAX MARKET, BY APPLICATION
CHAPTER 6: BONE WAX MARKET, BY END USER
CHAPTER 7: BONE WAX MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Companies Mentioned
Key Market Players in the Bone Wax Market include:- Zimmer Biomet Holdings, Inc.
- Medline Industries, Inc.
- Medtronic plc
- B Braun Melsungen AG
- Baxter International, Inc
- Johnson & Johnson
- Dolphin Sutures
- SMI AG
- Orion Sutures India Pvt. Ltd
- Universal Suture
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 280 |
| Published | July 2024 |
| Forecast Period | 2023 - 2033 |
| Estimated Market Value ( USD | $ 53.1 million |
| Forecasted Market Value ( USD | $ 73 million |
| Compound Annual Growth Rate | 3.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
